1214 related articles for article (PubMed ID: 1517373)
21. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
22. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
[TBL] [Abstract][Full Text] [Related]
23. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
24. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
Deutschbein T; Unger N; Hinrichs J; Walz MK; Mann K; Petersenn S
Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
[TBL] [Abstract][Full Text] [Related]
25. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
[TBL] [Abstract][Full Text] [Related]
26. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
27. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
Bernini GP; Argenio GF; Cerri F; Franchi F
J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
[TBL] [Abstract][Full Text] [Related]
28. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
[TBL] [Abstract][Full Text] [Related]
29. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
30. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
[TBL] [Abstract][Full Text] [Related]
31. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
32. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
33. Subclinical Cushing's syndrome in adrenal incidentalomas.
Sippel RS; Chen H
Surg Clin North Am; 2004 Jun; 84(3):875-85. PubMed ID: 15145240
[TBL] [Abstract][Full Text] [Related]
34. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
35. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas.
Chrisoulidou A; Rakitzi P; Boudina M; Apostolidou-Kiouti F; Poimenidou E; Papanikolaou A; Devlioti A; Rallis G; Pazaitou-Panayiotou K
Hormones (Athens); 2019 Mar; 18(1):85-89. PubMed ID: 30737657
[TBL] [Abstract][Full Text] [Related]
36. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
37. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
[TBL] [Abstract][Full Text] [Related]
38. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
